Research ArticleArticle

Mercaptopyruvate Inhibits Tissue-Nonspecific Alkaline Phosphatase and Calcium Pyrophosphate Dihydrate Crystal Dissolution

JOVIL V.A. KANNAMPUZHA, JINDRA H. TUPY and KENNETH P.H. PRITZKER
The Journal of Rheumatology December 2009, 36 (12) 2758-2765; DOI: https://doi.org/10.3899/jrheum.090098

REFERENCES

  1. 1.↵
    1. Flodgaard H,
    2. Fleron P
    . Thermodynamic parameters for the hydrolysis of inorganic pyrophosphate at pH 7.4 as a function of [Mg2+], [K+], and ionic strength determined from equilibrium studies of the reaction. J Biol Chem 1974;249:3465–73.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Van Wazer JR,
    2. Griffith EJ,
    3. McCullough JF
    . Structure and properties of the condensed phosphates. VII. Hydrolytic degradation of pyro- and tripolyphosphate. J Am Chem Soc 1955;77:287–91.
    OpenUrlCrossRef
  3. 3.↵
    1. Bennett RM,
    2. Lehr JR,
    3. McCarty DJ
    . Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest 1975;56:1571–9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Xu Y,
    2. Cruz TF,
    3. Cheng P-T,
    4. Pritzker KPH
    . Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1991;18:66–71.
    OpenUrlPubMed
  5. 5.↵
    1. Xu Y,
    2. Cruz TF,
    3. Pritzker KPH
    . Alkaline phosphatase dissolves calcium pyrophosphatase dihydrate crystals. J Rheumatol 1991;18:1606–10.
    OpenUrlPubMed
  6. 6.↵
    1. Xu Y,
    2. Pritzker KPH,
    3. Cruz TF
    . Characterization of chondrocyte alkaline phosphatase as a mediator in the dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1994;21:912–9.
    OpenUrlPubMed
  7. 7.↵
    1. Rees JA,
    2. Ali SY
    . Ultrastructural localization of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1988;47:747–53.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Pfander D,
    2. Swoboda B,
    3. Kirsch T
    . Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am J Pathol 2001;159:1777–83.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Fishman WH,
    2. Sie HG
    . Organ-specific inhibition of human alkaline phosphatase isoenzymes of liver, bone, intestine and placenta; L-phenylalanine, L-tryptophan and L-homoarginine. Enzymologia 1971;41:141–67.
    OpenUrlPubMed
  10. 10.↵
    1. Bodansky O
    . The inhibitory effects of DL-alanine, L-glutamic acid, L-lysine, and L-histidine on the activity of intestinal, bone and kidney phosphatases. J Biol Chem 1948;174:465–76.
    OpenUrlFREE Full Text
  11. 11.↵
    1. Brunel C,
    2. Cathala G
    . Imidazole: an inhibitor of L-phenylalanine-insensitive alkaline phosphatases of tissues other than intestine and placenta. Biochim Biophys Acta 1972;268:415–21.
    OpenUrlPubMed
  12. 12.↵
    1. Agus SG,
    2. Cox RP,
    3. Griffin MJ
    . Inhibition of alkaline phosphatase by cysteine and its analogues. Biochim Biophys Acta 1966;118:363–70.
    OpenUrlPubMed
  13. 13.↵
    1. Cox RP,
    2. Gilbert P Jr,
    3. Griffin MJ
    . Alkaline inorganic pyrophosphatase activity of mammalian-cell alkaline phosphatase. Biochem J 1967;105:155–61.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Griffin MJ,
    2. Cox C
    . Studies on the mechanism of substrate induction and L-cysteine repression of alkaline phosphatase in mammalian cell cultures. J Cell Sci 1967;2:545–55.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. So PP,
    2. Tsui FW,
    3. Vieth R,
    4. Tupy JH,
    5. Pritzker KP
    . Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 2007;34:1313–22.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Nagahara N,
    2. Sawada N
    . The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr Med Chem 2006;13:1219–30.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Kyoto encyclopedia of genes and genomes. Cysteine metabolism. [Internet. Accessed xxxx.] Available from: wwwgenomejp/dbget-bin/get_pathway?org_name=ko&mapno=00272 2009.
  18. 18.↵
    1. Cheng P-T,
    2. Pritzker KPH,
    3. Adams ME,
    4. Nyburg SC,
    5. Omar SA
    . Calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1980;7:609–16.
    OpenUrlPubMed
  19. 19.↵
    1. Hofstee BHJ
    . On the evaluation of the constants Vm and Km in enzyme reactions. Science 1952;116:329–31.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Kirsch PD,
    2. Ekerdt JG
    . KaleidaGraph: graphing and data analysis. Version 3.5 for Windows. Computer software reviews. J Am Chem Soc 2000;122:11755.
    OpenUrlCrossRef
  21. 21.↵
    1. Hase M
    . KaleidaGraph 3.0.5. for MacIntosh and Windows. Computer software reviews. J Am Chem Soc 1997;119:4323.
    OpenUrl
  22. 22.↵
    1. Tommasini R,
    2. Endrenyi L,
    3. Taylor PA,
    4. Mahuran DJ,
    5. Lowden JA
    . A statistical comparison of parameter estimation for the Michaelis-Menten kinetics of human placental hexosaminidiase. Can J Biochem Cell Biology 1985;63:225–30.
    OpenUrl
  23. 23.↵
    1. Cortes A,
    2. Cascante M,
    3. Cardenas ML,
    4. Cornish-Bowden A
    . Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 2001;357:263–8.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Cornish-Bowden A
    . A simple graphical method for determining the inhibition constants of mixed, uncompetitive and noncompetitive inhibitors. Biochem J 1974;137:143–4.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Cini R,
    2. Chindamo D,
    3. Catenaccio M,
    4. Lorenzini S,
    5. Selvi E,
    6. Nerucci F,
    7. et al.
    Dissolution of calcium pyrophosphate crystals by polyphosphates: an in vitro and ex vivo study. Ann Rheum Dis 2001;60:962–7.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Anderson HC,
    2. Garimella R,
    3. Tague SE
    . The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 2005;10:822–37.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Millan JL
    . Alkaline phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2006;2:335–41.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Millan JL
    . APs as therapeutic agents Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006:227–36.
  29. 29.↵
    1. Millan JL
    . The in vivo role of TNAP Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006:107–29.
  30. 30.↵
    1. Shinozaki T,
    2. Xu Y,
    3. Cruz TF,
    4. Pritzker KPH
    . Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals. J Rheumatol 1995;22:117–23.
    OpenUrlPubMed
  31. 31.↵
    1. Coleman JE
    . Structure and mechanism of alkaline phosphatase. Ann Rev Biophys Biomol Struct 1992;21:441–83.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Kim EE,
    2. Wyckof H
    . Structure of alkaline phosphatases. Clin Chim Acta 1990;186:175–87.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Jones AC,
    2. Chuck AJ,
    3. Arie EA,
    4. Green DJ,
    5. Doherty M
    . Diseases associated with calcium pyrophosphate deposition disease. Arthritis Rheum 1992;22:188–202.
    OpenUrlCrossRef
  34. 34.↵
    1. McKenna M,
    2. Hamilton T,
    3. Sussman H
    . Comparison of human alkaline phosphatase isoenzymes. Structural evidence for three protein classes. Biochem J 1979;181:67–73.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Cooper AJL
    . Biochemistry of sulfur-containing amino acids. Ann Rev Biochem 1983;52:187–222.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. McNearney T,
    2. Speegle D,
    3. Lawand NB,
    4. Lisse J,
    5. Westlund KN
    . Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27:739–45.
    OpenUrlPubMed
  37. 37.↵
    1. Fernstrom J,
    2. Wurtman R,
    3. Hammarstrom-Wiklund B,
    4. Rand W,
    5. Munro H,
    6. Davidson C
    . Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: Effect of dietary protein intake. Am J Clin Nutr 1979;32:1912–22.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Hunter GK,
    2. Grynpas MD,
    3. Cheng P-T,
    4. Pritzker KPH
    . Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels. Calcif Tissue Int 1987;41:164–70.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Brigham MP,
    2. Stein WH,
    3. Moore S
    . The concentrations of cysteine and cystine in human blood plasma. J Clin Invest 1960;39:1633–8.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Klassen P,
    2. Furst P,
    3. Schulz C,
    4. Mazariegos M,
    5. Solomons NW
    . Plasma free amino acid concentrations in healthy Guatemalan adults and in patients with classic dengue. Am J Clin Nutr 2001;73:647–52.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Lepage N,
    2. McDonald N,
    3. Dallaire L,
    4. Lambert M
    . Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem 1997;43:2397–402.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Ravaglia G,
    2. Forti P,
    3. Maioli F,
    4. Bianchi G,
    5. Sacchetti L,
    6. Talerico T,
    7. et al.
    Plasma amino acid concentrations in healthy and cognitively impaired oldest-old individuals: associations with anthropometric parameters of body composition and functional disability. Br J Nutr 2002;88:563–72.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Wancket LM,
    2. Baragi V,
    3. Bove S,
    4. Kilgore K,
    5. Korytko PJ,
    6. Guzman RE
    . Anatomical localization of cartilage degradation markers in a surgically induced rat osteoarthritis model. Toxicol Pathol 2005;33:484–9.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Rafii M,
    2. Elango R,
    3. Courtney-Martin G,
    4. House JD,
    5. Fisher L,
    6. Pencharz PB
    . High-throughput and simultaneous measurement of homocysteine and cysteine in human plasma and urine by liquid chromatography-electrospray tandem mass spectrometry. Anal Biochem 2007;371:71–81.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Derfus B,
    2. Steinberg M,
    3. Mandel N,
    4. Buday M,
    5. Daft L,
    6. Ryan L
    . Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystal in vitro. J Rheumatol 1995;22:1514–9.
    OpenUrlPubMed
  46. 46.↵
    1. Derfus BA,
    2. Rachow JW,
    3. Mandel NS,
    4. Boskey AL,
    5. Buday M,
    6. Kushnaryov VM,
    7. et al.
    Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992;35:231–40.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Ryan LM,
    2. Kurup I,
    3. Rosenthal AK,
    4. McCarty DJ
    . Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. Arch Biochem Biophys 1989;272:393–9.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

ALKALINE PHOSPHATASE
MERCAPTOPYRUVATE
AMINO ACIDS
CALCIUM PYROPHOSPHATE
ARTHRITIS
CARTILAGE

Keywords